These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1653329)

  • 1. Mass ligand binding screening for receptor antagonists: prototype new drugs and blind alleys.
    Burch RM
    J Recept Res; 1991; 11(1-4):101-13. PubMed ID: 1653329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new simple cell-based homogeneous time-resolved fluorescence QRET technique for receptor-ligand interaction screening.
    Härmä H; Rozwandowicz-Jansen A; Martikkala E; Frang H; Hemmilä I; Sahlberg N; Fey V; Perälä M; Hänninen P
    J Biomol Screen; 2009 Sep; 14(8):936-43. PubMed ID: 19684287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-molecule detection technologies in miniaturized high throughput screening: binding assays for g protein-coupled receptors using fluorescence intensity distribution analysis and fluorescence anisotropy.
    Rüdiger M; Haupts U; Moore KJ; Pope AJ
    J Biomol Screen; 2001 Feb; 6(1):29-37. PubMed ID: 11679163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current in vitro high throughput screening approaches to assess nuclear receptor activation.
    Raucy JL; Lasker JM
    Curr Drug Metab; 2010 Nov; 11(9):806-14. PubMed ID: 21189134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
    Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
    Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
    Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
    Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-receptor interactions in live cells by fluorescence correlation spectroscopy.
    Pramanik A
    Curr Pharm Biotechnol; 2004 Apr; 5(2):205-12. PubMed ID: 15078155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-based computational screening of compound databases: the main docking-scoring engines.
    Sperandio O; Miteva MA; Delfaud F; Villoutreix BO
    Curr Protein Pept Sci; 2006 Oct; 7(5):369-93. PubMed ID: 17073691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based nuclear magnetic resonance screening techniques.
    Viegas A; Macedo AL; Cabrita EJ
    Methods Mol Biol; 2009; 572():81-100. PubMed ID: 20694687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a generic dual-reporter gene assay for screening G-protein-coupled receptors.
    Kent TC; Thompson KS; Naylor LH
    J Biomol Screen; 2005 Aug; 10(5):437-46. PubMed ID: 16093553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
    Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
    J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
    Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO
    J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens.
    Bobach C; Tennstedt S; Palberg K; Denkert A; Brandt W; de Meijere A; Seliger B; Wessjohann LA
    Eur J Med Chem; 2015 Jan; 90():267-79. PubMed ID: 25461327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound profiling using a panel of steroid hormone receptor cell-based assays.
    Wilkinson JM; Hayes S; Thompson D; Whitney P; Bi K
    J Biomol Screen; 2008 Sep; 13(8):755-65. PubMed ID: 18753690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescent ligand-binding alternative using Tag-lite® technology.
    Zwier JM; Roux T; Cottet M; Durroux T; Douzon S; Bdioui S; Gregor N; Bourrier E; Oueslati N; Nicolas L; Tinel N; Boisseau C; Yverneau P; Charrier-Savournin F; Fink M; Trinquet E
    J Biomol Screen; 2010 Dec; 15(10):1248-59. PubMed ID: 20974902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target specific compound identification using a support vector machine.
    Plewczynski D; von Grotthuss M; Spieser SA; Rychlewski L; Wyrwicz LS; Ginalski K; Koch U
    Comb Chem High Throughput Screen; 2007 Mar; 10(3):189-96. PubMed ID: 17346118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
    Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
    Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists.
    Kinoyama I; Taniguchi N; Yoden T; Koutoku H; Furutani T; Kudoh M; Okada M
    Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1330-3. PubMed ID: 15516756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-ligand interactions studied with homogeneous fluorescence-based assays suitable for miniaturized screening.
    Scheel AA; Funsch B; Busch M; Gradl G; Pschorr J; Lohse MJ
    J Biomol Screen; 2001 Feb; 6(1):11-8. PubMed ID: 11679161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.